Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists
作者:Karin Worm、Damian G. Weaver、Rosalyn C. Green、Christopher T. Saeui、Doreen-Marie S. Dulay、William M. Barker、Joel A. Cassel、Gabriel J. Stabley、Robert N. DeHaven、Christopher J. LaBuda、Michael Koblish、Bernice L. Brogdon、Steven A. Smith、Roland E. Dolle
DOI:10.1016/j.bmcl.2009.07.057
日期:2009.9
benzamides were identified as a novel series of cannabinoid receptor ligands. Replacing the sulfonamide functionality and reversing the original carboxamide bond led to the discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists. Selective CB2 agonist 31 (Ki = 2.7; CB1/CB2 = 190) displayed robust activity in a rodent model of postoperative pain.
最近,氨磺酰基苯甲酰胺被确定为一系列新的大麻素受体配体。取代磺酰胺官能团并逆转原始的羧酰胺键导致发现N-(3-(吗啉代甲基)-苯基)-酰胺作为有效的和选择性的CB 2激动剂。选择性CB 2激动剂31(K i = 2.7; CB 1 / CB 2 = 190)在术后疼痛的啮齿动物模型中显示出强大的活性。